Medicare Enrolled
Dr. Scott Glazer, M.D.
Procedural Dermatology Physician · Buffalo Grove, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glazer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glazer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glazer
Dr. Scott Glazer is a procedural dermatology physician in Buffalo Grove, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Glazer performed 20,216 Medicare services across 10,103 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glazer received a total of $37,454 from 39 pharmaceutical and/or device companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glazer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 7% volume in IL
$37,454 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,216
Medicare services
Top 7% in IL for procedural dermatology physician
10,103
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~963 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
4,291 | $54 | $155 |
| Injection, tildrakizumab, 1 mg | 3,400 | $110 | $150 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,405 | $5 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,829 | $65 | $160 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
1,373 | $72 | $325 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,243 | $41 | $100 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,168 | $38 | $145 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
798 | $42 | $175 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
516 | $84 | $240 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
492 | $1 | $20 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
484 | $34 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
240 | $74 | $235 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
205 | $222 | $500 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
186 | $34 | $100 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
151 | $46 | $165 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
125 | $33 | $115 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
123 | $87 | $405 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
123 | $11 | $55 |
| Design and construction of complex radiation treatment device This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated. |
104 | $104 | $375 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $89 | $230 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
79 | $56 | $425 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
77 | $149 | $300 |
| Radiation treatment planning, complex This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment. |
69 | $363 | $850 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
60 | $61 | $210 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
58 | $123 | $340 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
55 | $241 | $660 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
52 | $121 | $600 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 50 | $263 | $645 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
38 | $99 | $365 |
| Skin cancer removal, face or mouth area, 0.6-1.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters. |
38 | $117 | $525 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
34 | $93 | $255 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
31 | $217 | $565 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
31 | $106 | $315 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
26 | $54 | $195 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
25 | $90 | $310 |
| Destruction of small cancerous skin growth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 cm or less on the scalp, neck, hands, feet, or genitals. |
24 | $102 | $330 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
23 | $77 | $325 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 22 | $123 | $410 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
19 | $110 | $545 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
18 | $51 | $200 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
18 | $138 | $565 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
14 | $186 | $520 |
| Removal of noncancer skin growth, face/ears/eyelids/nose/lips/mouth, 0.6-1.0 cm This procedure involves the surgical removal of a benign skin growth from the face, ears, eyelids, nose, lips, or mouth. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
13 | $109 | $370 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$37,454
Total received (2018-2024)
Avg $5,351/year across 7 years
Top 29% in IL for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
543
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,761 (66.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,617 (17.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,076 (16.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,473
2023
$4,484
2022
$16,998
2021
$5,135
2020
$682
2019
$1,179
2018
$4,503
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,491
GENZYME CORPORATION
$323
Lilly USA, LLC
$199
Arcutis Biotherapeutics, Inc.
$79
LEO Pharma Inc.
$74
E.R. Squibb & Sons, L.L.C.
$55
Smith+Nephew, Inc.
$38
Regeneron Healthcare Solutions, Inc.
$34
Galderma Laboratories, L.P.
$30
Verrica Pharmaceuticals Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Novartis Pharmaceuticals Corporation
$25
UCB, Inc.
$24
Genentech USA, Inc.
$22
PFIZER INC.
$14
MAYNE PHARMA COMMERCIAL LLC
$10
Top 3 companies account for 89.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$18,841
ABBVIE INC.
$7,747
Janssen Biotech, Inc.
$4,151
EPI Health, LLC
$1,586
Allergan Inc.
$860
GENZYME CORPORATION
$546
Merz North America, Inc.
$466
Galderma Laboratories, L.P.
$368
Sun Pharmaceutical Industries Inc.
$355
Lilly USA, LLC
$284
PFIZER INC.
$271
Regeneron Healthcare Solutions, Inc.
$259
Amgen Inc.
$213
UCB, Inc.
$171
AbbVie Inc.
$168
Novartis Pharmaceuticals Corporation
$137
E.R. Squibb & Sons, L.L.C.
$123
AbbVie, Inc.
$116
Genentech USA, Inc.
$88
Arcutis Biotherapeutics, Inc.
$79
LEO Pharma Inc.
$74
SUN PHARMACEUTICAL INDUSTRIES INC.
$58
Dermavant Sciences, Inc.
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Incyte Corporation
$49
Ortho Dermatologics, a division of Bausch Health US, LLC
$43
Kyowa Kirin, Inc.
$42
Smith+Nephew, Inc.
$38
Verrica Pharmaceuticals Inc.
$29
MAYNE PHARMA COMMERCIAL LLC
$28
Organogenesis Inc.
$27
Janssen Scientific Affairs, LLC
$27
VYNE Pharmaceuticals Inc.
$24
Biofrontera Inc.
$15
Mylan Pharmaceuticals Inc.
$14
Taro Pharmaceuticals USA, Inc.
$14
Encore Dermatology Inc.
$14
Mayne Pharma Inc.
$14
Sensus Healthcare, Inc.
$11
Top 3 companies account for 82.1% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · BLU-U · BOTOX · BOTOX COSMETIC · Bensal HP · CIBINQO · CLODERM · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · GRAFIX PL · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · LIBTAYO · OPZELURA · ORACEA · Olux-E · Otezla · POTELIGEO · Puraply · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · VTAMA · WYNZORA · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in procedural dermatology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Procedural dermatology physicians within 10 mi
10
Per 100K population
1.4
County median income
$108,917
Nearest hospital
NORTHWESTERN LAKE FOREST HOSPITAL
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glazer is a clinical cardiology specialist, with above-average Medicare volume (top 7% in IL), with speaking/promotional industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glazer experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Glazer performed 4,291 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glazer receive payments from pharmaceutical companies?
Yes. Dr. Glazer received a total of $37,454 from 39 companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glazer's costs compare to other procedural dermatology physicians in Buffalo Grove?
Dr. Glazer's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glazer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Buffalo Grove
Browse procedural dermatology physicians in Buffalo Grove ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in IL
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in IL
Which IL procedural dermatology physicians receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology